Stay updated on 89Zr-Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.
Latest updates to the 89Zr-Pembrolizumab in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the intervention details to include verification by Prof. dr. E.F. Smit and changed the revision from v2.13.3 to v2.14.0, while removing the previous type of intervention.SummaryDifference1.0%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check53 days agoChange DetectedSeveral key URLs related to genetics and lung cancer, as well as various data fields and options for downloading study information, have been removed from the website.SummaryDifference4%
- Check68 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links related to genetics and lung cancer, as well as detailed data fields for study information, while removing the previous version 2.12.1 and a 'Show less' option.SummaryDifference5%
- Check75 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to 89Zr-Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.